Task A92: Efficacy of Antiviral Therapeutics Against MERS-CoV in a Mouse-Adapted Virus Model

NIH RePORTER · NIH · N01 · $637,479 · view on reporter.nih.gov ↗

Abstract

This contract provides for the development of new and refinement of existing models of infectious diseases and may include evaluation of candidate countermeasures.

Key facts

NIH application ID: 11197721
Project number: 272201700036I-0-759302400001-1
Recipient: UNIV OF NORTH CAROLINA CHAPEL HILL
Principal Investigator: RALPH BARIC
Activity code: N01
Funding institute: NIH
Fiscal year: 2024
Award amount: $637,479
Award type: —
Project period: 2017-07-14 → 2024-08-13